Genzyme Corp. et al v. Cipla Limited
| The Regents of the University of Michigan and Genzyme Corp. |
| Cipla Limited |
| 1:2018cv01838 |
| November 20, 2018 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 16, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re (14 in 1:18-cv-01838-CFC, 11 in 1:18-cv-01839-CFC, 13 in 1:18-cv-01796-CFC, 12 in 1:18-cv-01837-CFC) MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Michael E. Furrow, Daniel J. Minion, Damien N. Dombrowski and Katherine E. Adams of Venable LLP filed by The Regents of the University of Michigan, Genzyme Corp. Signed by Judge Colm F. Connolly on 1/11/2019. Associated Cases: 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(fms)
|
|
Filing 15
Order Setting Scheduling Conference: A Scheduling Conference is set for 1/31/2019 at 04:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/11/2019. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(nmf)
|
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Michael E. Furrow, Daniel J. Minion, Damien N. Dombrowski and Katherine E. Adams of Venable LLP - filed by Genzyme Corp., The Regents of the University of Michigan. (Fahnestock, Derek) |
| Filing 13 ANSWER to #9 Answer to Complaint, Counterclaim /Plaintiffs' Answer to the Counterclaims of Defendant Cipla Limited by Genzyme Corp., The Regents of the University of Michigan.(Fahnestock, Derek) |
| Pro Hac Vice Attorney Jitendra Malik and Alissa M. Pacchioli for Cipla Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Jitendra Malik, Ph.D. and Alissa M. Pacchioli filed by Cipla Limited. Signed by Judge Colm F. Connolly on 1/4/2019. (fms)
|
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Jitendra Malik, Ph.D. and Alissa M. Pacchioli - filed by Cipla Limited. (Attachments: #1 Certification of Jitendra Malik, Ph.D., #2 Certification of Alissa M. Pacchioli)(Bilson, David) |
| Filing 11 Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding proposed joint scheduling conference. (Blumenfeld, Jack) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cipla Limited. (Phillips, John) |
| Filing 9 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Cipla Limited.(Phillips, John) |
|
Filing 8
ORDER, IT IS ORDERED that, on or before December 28, 2018, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/28/2018.) Signed by Judge Colm F. Connolly on 12/12/2018. Associated Cases: 1:18-cv-01795-CFC, 1:18-cv-01796-CFC, 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC(nmf)
|
| Filing 7 STIPULATION TO EXTEND TIME for Cipla Limited to answer, plead or otherwise respond to the Complaint (D.I. 1) to December 19, 2018 - filed by Cipla Limited. (Phillips, John) |
|
SO ORDERED, re #7 STIPULATION TO EXTEND TIME for Cipla Limited to answer, plead or otherwise respond to the Complaint (D.I. 1) to December 19, 2018 filed by Cipla Limited. Set/Reset Answer Deadlines: Cipla Limited answer due 12/19/2018. Signed by Judge Colm F. Connolly on 12/7/2018. (fms)
|
| Filing 6 DECLARATION of Mailing on Cipla Limited by Genzyme Corp., The Regents of the University of Michigan. (Fahnestock, Derek) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01837-CFC, 1:18-cv-01838-CFC, 1:18-cv-01839-CFC (rjb) |
| Summons Issued with Magistrate Consent Notice attached as to Cipla Limited on 11/21/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aventis Inc. for Genzyme Corp. filed by Genzyme Corp., The Regents of the University of Michigan. (ceg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,196,205 B2; 6,916,802 B2; 7,253,185 B2; 7,615,573 B2. (ceg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/12/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 2/19/2022. (ceg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2508869.) - filed by The Regents of the University of Michigan, Genzyme Corp. (Attachments: #1 Exhibits A-D, #2 Civil Cover Sheet)(ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
